IPDN-China promotes the development of pediatric dialysis in China.


Journal

Pediatric nephrology (Berlin, Germany)
ISSN: 1432-198X
Titre abrégé: Pediatr Nephrol
Pays: Germany
ID NLM: 8708728

Informations de publication

Date de publication:
11 2020
Historique:
received: 30 12 2019
accepted: 27 05 2020
revised: 16 05 2020
pubmed: 13 6 2020
medline: 21 7 2021
entrez: 13 6 2020
Statut: ppublish

Résumé

In mainland China, dialysis for children with end-stage renal disease (ESRD) was not introduced until the 1980s. To describe the development of pediatric dialysis in different regions of China, a national pediatric dialysis network, namely, International Pediatric Dialysis Network-China (IPDN-China) ( www.pedpd.org.cn ), was launched in 2012. Original and updated information from the renal centers registered with the IPDN-China was collected between 2012 and 2016 from two sources, namely, the registry and the survey, and demographic features were analyzed. Due to promotion by the IPDN-China, the number of registered renal centers increased from 12 to 39 between 2012 and 2016, with a significant increase in the coverage of the Chinese administrative divisions (from 26.5 to 67.6%) (p < 0.01); and the coverage of the pediatric (0~14 years old) population increased to nearly 90% in 2016. The distribution of renal centers indicated that East China had the highest average number of registered centers per million population (pmp) 0~14-year-old age group. Seventeen relatively large dialysis centers were distributed across 14 divisions. Various modalities of renal replacement therapy (RRT) were available in most centers. The IPDN-China has promoted collaborations between dieticians, psychologists, and social workers on dialysis teams to provide better service to children with ESRD and their families. The proportion of centers with all three types of paramedic support (i.e., dieticians, psychologists, and social workers) as well as the proportion of centers with a partial paramedic team significantly increased between 2012 (25.0%) and 2016 (69.2%) (p < 0.05). In terms of the point prevalent cases of patients (aged < 18 years), data from the survey of 39 registered centers revealed that the number of children with ESRD who were on RRT was 578 (49% received a kidney transplant) at the end of 2016, which was more than that reported in previous surveys. Data from the registry showed that 349 dialysis patients had been enrolled as of the end of 2016. The median age at RRT start was 9.5 years, and the leading cause of ESRD was congenital abnormalities of the kidney and urinary tract (CAKUT). The IPDN-China has helped to promote the development of pediatric dialysis for ESRD in China by improving the organization of care for dialysis patients and increasing the availability and the quality of RRT for patients who need it. To improve knowledge about the epidemiology and outcomes of pediatric RRT around the country, a sustained effort needs to be made by the IPDN-China to increase the enrollment of dialysis patients and increase the number of registered centers in the future.

Sections du résumé

BACKGROUND
In mainland China, dialysis for children with end-stage renal disease (ESRD) was not introduced until the 1980s. To describe the development of pediatric dialysis in different regions of China, a national pediatric dialysis network, namely, International Pediatric Dialysis Network-China (IPDN-China) ( www.pedpd.org.cn ), was launched in 2012.
METHODS
Original and updated information from the renal centers registered with the IPDN-China was collected between 2012 and 2016 from two sources, namely, the registry and the survey, and demographic features were analyzed.
RESULTS
Due to promotion by the IPDN-China, the number of registered renal centers increased from 12 to 39 between 2012 and 2016, with a significant increase in the coverage of the Chinese administrative divisions (from 26.5 to 67.6%) (p < 0.01); and the coverage of the pediatric (0~14 years old) population increased to nearly 90% in 2016. The distribution of renal centers indicated that East China had the highest average number of registered centers per million population (pmp) 0~14-year-old age group. Seventeen relatively large dialysis centers were distributed across 14 divisions. Various modalities of renal replacement therapy (RRT) were available in most centers. The IPDN-China has promoted collaborations between dieticians, psychologists, and social workers on dialysis teams to provide better service to children with ESRD and their families. The proportion of centers with all three types of paramedic support (i.e., dieticians, psychologists, and social workers) as well as the proportion of centers with a partial paramedic team significantly increased between 2012 (25.0%) and 2016 (69.2%) (p < 0.05). In terms of the point prevalent cases of patients (aged < 18 years), data from the survey of 39 registered centers revealed that the number of children with ESRD who were on RRT was 578 (49% received a kidney transplant) at the end of 2016, which was more than that reported in previous surveys. Data from the registry showed that 349 dialysis patients had been enrolled as of the end of 2016. The median age at RRT start was 9.5 years, and the leading cause of ESRD was congenital abnormalities of the kidney and urinary tract (CAKUT).
CONCLUSIONS
The IPDN-China has helped to promote the development of pediatric dialysis for ESRD in China by improving the organization of care for dialysis patients and increasing the availability and the quality of RRT for patients who need it. To improve knowledge about the epidemiology and outcomes of pediatric RRT around the country, a sustained effort needs to be made by the IPDN-China to increase the enrollment of dialysis patients and increase the number of registered centers in the future.

Identifiants

pubmed: 32529322
doi: 10.1007/s00467-020-04630-3
pii: 10.1007/s00467-020-04630-3
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2163-2171

Auteurs

Yihui Zhai (Y)

Division of Nephrology, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Children's Hospital of Fudan University, No. 399 Wanyuan Rd, Shanghai, 201102, People's Republic of China.

Xiaorong Liu (X)

Division of Nephrology, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Rd., West City District, Beijing, 100045, People's Republic of China.

Qing Yang (Q)

Division of Nephrology, Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China.

Xiqiang Dang (X)

Division of Pediatric Nephrology, The Second Xiangya Hospital of Central South University, Changsha, China.

Shuzhen Sun (S)

Division of Pediatric Nephrology, Shandong Provincial Hospital, Jinan, China.

Xiaoshan Shao (X)

Division of Nephrology, Guiyang Children's Hospital, Guiyang, China.

Xuemei Liu (X)

Division of Nephrology, Qilu Children's Hospital of Shandong University, Jinan, China.

Yubin Wu (Y)

Division of Pediatric Nephrology, Shengjing Hospital of China Medical University, Shenyang, China.

Haitao Bai (H)

Division of Pediatric Nephrology, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Jianhua Mao (J)

Division of Nephrology, The Children's Hospital of Zhejiang University School of Medicine, Hangzhou, China.

Yang Dong (Y)

Division of Nephrology, Anhui Provincial Children's Hospital, Hefei, China.

Qingshan Ma (Q)

Division of Pediatric Nephrology, The First Hospital of Jilin University, Changchun, China.

Guogui Kang (G)

Division of Pediatric Nephrology, Ningbo Women and Children's Hospital, Ningbo, China.

Wenyan Huang (W)

Division of Nephrology, Shanghai Children's Hospital, Shanghai, China.

Hongtao Zhu (H)

Division of Pediatric Nephrology, The First Hospital of Xinjiang Medical University, Urumqi, China.

Rui Fu (R)

Division of Nephrology, Jiangxi Children's Hospital, Nanchang, China.

Aihua Zhang (A)

Division of Nephrology, Nanjing Children's Hospital, Nanjing, China.

Ruiying Xu (R)

Division of Pediatric Nephrology, Qilu Hospital of Shandong University, Jinan, China.

Qing Sun (Q)

Division of Pediatric Nephrology, Qingdao Women and Children's Hospital, Qingdao, China.

Xiaoyun Jiang (X)

Division of Pediatric Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.

Liwen Lai (L)

Division of Pediatric Nephrology, The third People's Hospital of Jingdezhen, Nanchang, China.

Jianping Huang (J)

Division of Nephrology, Bayi Children's Hospital, The Military General Hospital of Beijing PLA, Beijing, China.

Jiangwei Luan (J)

Division of Pediatric Nephrology, Wuhan Women and Children's Hospital, Wuhan, China.

Zhengkun Xia (Z)

Division of Pediatric Nephrology, National Clinical Research Center of Kidney Disease, Jinlin Hospital, Nanjing, China.

Jianjun Cui (J)

Division of Nephrology, Shanxi Children's Hospital, Taiyuan, China.

Mengzhun Zhao (M)

Division of Pediatric Nephrology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.

Xiaolin Wu (X)

Division of Pediatric Nephrology, Hubei Women and Children's Hospital, Wuhan, China.

Qiuye Zhang (Q)

Division of Pediatric Nephrology, The Affiliated Hospital of Qingdao University, Qingdao, China.

Yufeng Li (Y)

Division of Pediatric Nephrology, Xin Hua Hospital Affiliated, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Cuihua Liu (C)

Division of Nephrology, Henan Children's Hospital, Henan, China.

Mo Wang (M)

Division of Nephrology, Children's Hospital of Chongqing Medical University, Chongqing, China.

Feiyan Wang (F)

Division of Nephrology, Urumqi Children's Hospital, Urumqi, China.

Yuhong Tao (Y)

Division of Pediatric Nephrology, West China Second University Hospital, Chengdu, China.

Zhimin Huang (Z)

Division of Pediatric Nephrology, The Affiliated Hospital of Guangdong University, Guangzhou, China.

Dongfeng Zhang (D)

Division of Nephrology, Children's Hospital of Hebei Province, Shijiazhuang, China.

Bo Zhao (B)

Division of Nephrology, Kunming Children's Hospital, Kunming, China.

Chaoying Chen (C)

Division of Nephrology, Children's Hospital, Capital Institute of Pediatrics, Beijing, China.

Chunlin Huang (C)

Division of Nephrology, The Maternal and Child Health Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Xia Gao (X)

Division of Pediatric Nephrology, Gansu Provincial Hospital, Lanzhou, China.

Qian Shen (Q)

Division of Nephrology, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Children's Hospital of Fudan University, No. 399 Wanyuan Rd, Shanghai, 201102, People's Republic of China. shenqian@shmu.edu.cn.

Ying Shen (Y)

Division of Nephrology, Beijing Children's Hospital, Capital Medical University, No. 56 Nanlishi Rd., West City District, Beijing, 100045, People's Republic of China. shenying@bch.com.cn.

Hong Xu (H)

Division of Nephrology, Shanghai Kidney Development and Pediatric Kidney Disease Research Center, Children's Hospital of Fudan University, No. 399 Wanyuan Rd, Shanghai, 201102, People's Republic of China. hxu@shmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH